Latest filing published 14 Feb 2017 for DiaMedica Therapeutics Inc., €853.
Filing timeline
BuySaleInsider track record
Paul Papi: trading record in brief
Paul Papi is a declared insider of DiaMedica Therapeutics Inc., with filings sourced from SEC (Form 4). Between 6 February 2017 and 7 February 2017, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €4,949. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 14 February 2017 came the latest disclosure, an open-market purchase for €853 in DiaMedica Therapeutics Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Paul Papi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.